Salazosulfapyridine-induced hypersensitivity syndrome triggered by methotrexate.
Teraki
Y
Y
Izaki
S
S
D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D003875:Drug Eruptions / Q000209:etiology*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008727:Methotrexate / Q000009:adverse effects*; D008875:Middle Aged; D012460:Sulfasalazine / Q000009:adverse effects*
D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D012460:Sulfasalazine; D008727:Methotrexate